BIT 0.00% 2.2¢ biotron limited

$10 Billion Deal, page-13026

  1. 14,088 Posts.
    lightbulb Created with Sketch. 2408
    While I do agree with you about BIT225 being a good candidate as the next gen anti-viral - and I hope this will be an avenue that BIT engages in. The situation is that the trials have not been don on this application.

    Information can b gleaned from the two trials BUT there would need to be a separate set of trials to test the anti-viral potential.

    This is why trials are done in the first place.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.